Biotech

All Articles

Turnstone gives up 60%, shakes up C-suite to stretch out money

.Turnstone Biologics is reducing its headcount through 60% and shocking its C-suite in order to keep...

Gilead surrenders on $15M MASH bet after weighing preclinical records

.In a year that has actually viewed a confirmation and also a range of readouts for metabolic dysfun...

Texas biotech centers cancer pact, pins wishes on weight problems

.Alaunos Therapeutics is axing an arrangement with Precigen, giving up licensing civil rights to a p...

Capricor allotments more data for DMD therapy after launching BLA

.Capricor Therapeutics is actually taking a success tour for their period 2 Duchenne muscle dystroph...

FDA locations Kezar lupus trial in grip observing 4 patient fatalities

.The FDA has positioned Kezar Life Sciences' lupus trial on grip after the biotech warned 4 deaths i...

Phase 3 Scholar Stone trial reaches SMA objective, sending stock up 200%

.A period 3 test of Intellectual Rock's back muscular degeneration (SMA) prospect has actually attac...

CAMP 4 is latest to eye IPO, while Upstream spells out $182M plan

.RNA biotech CAMP4 Therapies has defined prepare for a $67 million IPO, along with inflammation-focu...

Galecto gets leukemia drug, drops bone cancer asset in pivot

.A year after the breakdown of an idiopathic lung fibrosis prospect sent Galecto on a hunt for redem...

Judo throws down $100M to knock out renal disease

.Taking the mat is Judo Bio, a promising biotech armed with $100 thousand to cultivate oligonucleoti...

AstraZeneca pays out CSPC $100M for preclinical heart disease medicine

.AstraZeneca has paid off CSPC Pharmaceutical Group $one hundred million for a preclinical cardiovas...